Publications & Works

Publication Network
Articles 6
All (6)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (6)
Scopus (6)

1. Serum Elafin as a Potential Marker of Disease Activity in Behçet's Disease

Kutlay A., Kose A. A.
Indian Journal of Dermatology , vol.68, no.4, pp.372-376, 2023 (SCI-Expanded, Scopus) identifier identifier

2. Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey

Kobaner G. B., Ekinci A. P., Kutlay A.
DERMATOLOGIC THERAPY , vol.34, no.4, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

3. The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study.

Baykal C., Atci T., Buyukbabani N., Kutlay A.
Indian journal of dermatology , vol.64, no.5, pp.392-399, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

4. Complete healing of basal cell carcinoma under bendamustine and brentuximab vedotin therapy in a patient with cutaneous lymphoma

Baykal C., Kutlay A., Buyukbabani N.
DERMATOLOGIC THERAPY , vol.32, no.4, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

5. Treatment of recalcitrant generalized morphea with mycophenolate mofetil and intravenous immunoglobulin.

Kuecuekoglu R., Yilmaz Z., Kutlay A.
Dermatologic therapy , vol.31, no.5, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

6. Varenicline-induced acute generalized exanthematous pustulosis confirmed by patch testing.

Özkaya E., YAZGANOGLU K. D., KUTLAY A., MAHMUDOV A.
Contact dermatitis , vol.78, pp.97-99, 2018 (SCI-Expanded, Scopus) identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 2

1. Successful Treatment of Recalcitrant Pediatric Generalized Pustular Psoriasis Patients with anti TNF-alpha therapy: A Case Series from a Tertiary Center in Turkey

POLAT EKİNCİ A., BABUNA KOBANER G., Sun G. P., KUTLAY A.
24th World Congress of Dermatology, Milano, Italy, 10 - 15 June 2019, pp.143, (Summary Text)

2. Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center

BABUNA KOBANER G., KUTLAY A.
4th INDERCOS Congress, İstanbul, Turkey, 27 - 30 March 2019, pp.221, (Summary Text)
Metrics

Publication

8

Publication (WoS)

6

Publication (Scopus)

6

Citation (WoS)

20

H-Index (WoS)

2

Citation (Scopus)

28

H-Index (Scopus)

2
UN Sustainable Development Goals